Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 265.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 265.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 265.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\29524844
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Redox+Biol
2018 ; 16
(ä): 215-225
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Hyperhomocysteinemia potentiates diabetes-impaired EDHF-induced vascular
relaxation: Role of insufficient hydrogen sulfide
#MMPMID29524844
Cheng Z
; Shen X
; Jiang X
; Shan H
; Cimini M
; Fang P
; Ji Y
; Park JY
; Drosatos K
; Yang X
; Kevil CG
; Kishore R
; Wang H
Redox Biol
2018[Jun]; 16
(ä): 215-225
PMID29524844
show ga
Insufficient hydrogen sulfide (H(2)S) has been implicated in Type 2 diabetic
mellitus (T2DM) and hyperhomocysteinemia (HHcy)-related cardiovascular
complications. We investigated the role of H(2)S in T2DM and HHcy-induced
endothelial dysfunction in small mesenteric artery (SMA) of db/db mice fed a high
methionine (HM) diet. HM diet (8 weeks) induced HHcy in both T2DM db/db mice and
non-diabetic db/+ mice (total plasma Hcy: 48.4 and 31.3?µM, respectively), and
aggravated the impaired endothelium-derived hyperpolarization factor
(EDHF)-induced endothelium-dependent relaxation to acetylcholine (ACh),
determined by the presence of eNOS inhibitor N(?)-nitro-L-arginine methyl ester
(L-NAME) and prostacyclin (PGI(2)) inhibitor indomethacin (INDO), in SMA from
db/db mice but not that from db/+ mice. A non-selective Ca(2+)-active potassium
channel (K(Ca)) opener NS309 rescued T2DM/HHcy-impaired EDHF-mediated vascular
relaxation to ACh. EDHF-induced relaxation to ACh was inhibited by a
non-selective K(Ca) blocker TEA and intermediate-conductance K(Ca) blocker
(IK(Ca)) Tram-34, but not by small-conductance K(Ca) (SK(Ca)) blocker Apamin.
HHcy potentiated the reduction of free sulfide, H(2)S and cystathionine ?-lyase
protein, which converts L-cysteine to H(2)S, in SMA of db/db mice. Importantly, a
stable H(2)S donor DATS diminished the enhanced O(2)(-) production in SMAs and
lung endothelial cells of T2DM/HHcy mice. Antioxidant PEG-SOD and DATS improved
T2DM/HHcy impaired relaxation to ACh. Moreover, HHcy increased
hyperglycemia-induced IK(Ca) tyrosine nitration in human micro-vascular
endothelial cells. EDHF-induced vascular relaxation to L-cysteine was not
altered, whereas such relaxation to NaHS was potentiated by HHcy in SMA of db/db
mice which was abolished by ATP-sensitive potassium channel blocker Glycolamide
but not by K(Ca) blockers. CONCLUSIONS: Intermediate HHcy potentiated H(2)S
reduction via CSE-downregulation in microvasculature of T2DM mice. H(2)S is
justified as an EDHF. Insufficient H(2)S impaired EDHF-induced vascular
relaxation via oxidative stress and IK(Ca) inactivation in T2DM/HHcy mice. H(2)S
therapy may be beneficial for prevention and treatment of micro-vascular
complications in patients with T2DM and HHcy.